Evidence map›Paper›PMID 38822154›Full record

ArticleEuropean journal of orthopaedic surgery & traumatology : orthopedie traumatologie2024

Multi-center study of use of the Exeter stem in Japan: a 10-year follow-up report.

Tatsuro Sakurai, Hiroshi Fujita, Toshiki Iwase, Kan Sasaki, Naoyuki Katayama, Hiromi Otsuka

Abstract readMulticenter Study
In one paragraph

Article in European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tatsuro SakuraiDepartment of Orthopedic Surgery, Nagareyama Central Hospital, 2-243-3 Higashihatsuishi, Nagareyama-shi, Chiba, 270-0114, Japan. sakuraitatsuro@gmail.com.
Hiroshi FujitaCenter for Hip Arthroplasty, Senshunkai Hospital, Nagaokakyo-shi, Kyoto, 617-0826, Japan.
Toshiki IwaseDepartment of Orthopedic Surgery, Hamamatsu Medical Center, Hamamatsu, Shizuoka, 432-8580, Japan.
Kan SasakiDepartment of Orthopedic Surgery, Yamagata Saisei Hospital, Okimachi, Yamagata, 990-8545, Japan.
Naoyuki KatayamaDepartment of Orthopedic Surgery, Hokkaido Orthopedic Memorial Hospital, Sapporo, Hokkaido, 062-0937, Japan.
Hiromi OtsukaDepartment of Orthopedic Surgery, School of Medicine, Aichi Medical University, Nagakute-shi, Aichi, 480-1195, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeSince the introduction of the Exeter stem for clinical use in Japan in 1996, the number of stems used has continued to rise owing to its favorable results. We investigated the outcomes of patients who had previously undergone total hip arthroplasty with the Exeter stem in Japan with a 10-year + follow-up period.

methodsThis retrospective cohort study used clinical and radiographic data of 682 cases of primary total hip arthroplasty performed using the Exeter stem.

resultsThe mean postoperative follow-up period was 13.3 years. Femoral-side revision was required in 14 hips, with no cases of aseptic stem loosening-associated revision observed. Kaplan-Meier survival analysis predicted 97.3% 15-year survival when revision for any reason was used as the endpoint.

conclusionThe obtained findings suggested the excellent long-term stability of the Exeter stem for primary total hip arthroplasty in Japan.

Indexed as

Arthroplasty, Replacement, HipHip ProsthesisReoperationAdultAgedAged, 80 and overFemaleFollow-Up StudiesHumansJapanKaplan-Meier EstimateMaleMiddle AgedProsthesis DesignProsthesis FailureRetrospective StudiesBone cementsMulticenter studySurvival analysisTotal hip arthroplasty

Identifiers

PMID38822154
PMCPMC11377650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.